Skip to main content
Fig. 7 | BMC Bioinformatics

Fig. 7

From: LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients

Fig. 7

Immune infiltration analysis of ZNF529-AS1 in the HCC microenvironment. A Correlation analysis between ZNF529-AS1 and immune cells; B Wilcoxon test analysis of TIICs of HCC patients with high expression and low expression of ZNF529-AS1; C and D differential analysis of immune function and immune checkpoints between HCC patients with high expression and low expression of ZNF529-AS1; differences in the E immune score, F stromal score, G ESTIMATE score, and H tumour purity between the ZNF529-AS1 high expression and low expression groups (*p < 0.05; **p < 0.01; ***p < 0.001)

Back to article page